choline and Dyslipidemias studies

choline and Dyslipidemias

choline has been researched along with Dyslipidemias in 2 studies

Dyslipidemias: Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.

Research Excerpts

Excerpt	Relevance	Reference
"Dyslipidemia is an important modifiable risk factor."	6.46	The role of a new formulation of fenofibric acid in the treatment of mixed dyslipidemia in type 2 diabetes. ( Campbell, J; Mohiuddin, SM, 2010)
"Higher triglyceride and lower HDL levels statistically account for the association between BMI and myo-inositol, pointing toward a potentially critical role for dyslipidemia in the development of cerebral neurochemical alterations in obesity."	3.79	Dyslipidemia links obesity to early cerebral neurochemical alterations. ( Gonzales, MM; Haley, AP; Tanaka, H; Tarumi, T, 2013)
"Dyslipidemia is an important modifiable risk factor."	2.46	The role of a new formulation of fenofibric acid in the treatment of mixed dyslipidemia in type 2 diabetes. ( Campbell, J; Mohiuddin, SM, 2010)

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

0 (0.00)

29.6817

2010's

2 (100.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Haley, AP	1
Gonzales, MM	1
Tarumi, T	1
Tanaka, H	1
Campbell, J	1
Mohiuddin, SM	1

Studies

Haley, AP

Gonzales, MM

Tarumi, T

Tanaka, H

Campbell, J

Mohiuddin, SM

Reviews

1 review available for choline and Dyslipidemias

Article	Year
The role of a new formulation of fenofibric acid in the treatment of mixed dyslipidemia in type 2 diabetes. Drugs of today (Barcelona, Spain : 1998), 2010, Volume: 46, Issue:10 Topics: Choline; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Dyslipidemias; Fenofibrate; Humans; H	2010

Article

Year

The role of a new formulation of fenofibric acid in the treatment of mixed dyslipidemia in type 2 diabetes.

Drugs of today (Barcelona, Spain : 1998), 2010, Volume: 46, Issue:10

Topics: Choline; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Dyslipidemias; Fenofibrate; Humans; H

2010

Other Studies

1 other study available for choline and Dyslipidemias

Article	Year
Dyslipidemia links obesity to early cerebral neurochemical alterations. Obesity (Silver Spring, Md.), 2013, Volume: 21, Issue:10 Topics: Adult; Aspartic Acid; Blood Glucose; Blood Pressure; Body Mass Index; Brain; Brain Diseases; Cholest	2013

Article

Year

Dyslipidemia links obesity to early cerebral neurochemical alterations.

Obesity (Silver Spring, Md.), 2013, Volume: 21, Issue:10

Topics: Adult; Aspartic Acid; Blood Glucose; Blood Pressure; Body Mass Index; Brain; Brain Diseases; Cholest

2013